Abstract
In type 1 diabetes, a failure in the regulation of either innate or acquired immunity may be the cause of autoimmune response. A cell population that may have a regulatory role of the immune response are the Natural Killer T (NKT) cells, which are a population expressing T lymphocyte antigen receptor (TCR), and a common marker for NK cells. A distinctive characteristic in NKT cells is their capacity to produce large amounts of immune-modulating cytokines. A decrease in the number and/or functional incapability of NKT cells is associated with progression of type 1 diabetes and with other self-immune diseases. However, the relevance of such findings is not completely understood. Limitations of the current studies include the existing methods to measure NKT activation and the lack of assessment of the expression of genes affected by NKT action. Nevertheless, the study of NKT cells may be a new clinical approach to detect individuals at risk for having type 1 diabetes. Additional studies are needed to evaluate the clinical value of this new predictive tool.
Keywords: Natural Killer T (NKT) cells, Type 1 diabetes, Class-I MHC-restricted T-cell associated molecule (CRTAM), T lymphocyte antigen receptor (TCR), Effector lymphocytes, Human Leukocytary Antigen (HLA), Tumor Necrosis Factor, Insulitis, Hyperglycemia, Immunoglobulin
Current Diabetes Reviews
Title: The Role of Natural Killer T (NKT) Cells in the Pathogenesis of Type 1 Diabetes
Volume: 7 Issue: 4
Author(s): Rita A. Gomez-Diaz, Mayra V. Aguilar, Elisa N. Meguro, Rocio H. Marquez, Eulalia G. Magana, M. Carmen Martinez-Garcia, Niels W. Rodarte, Carlos A. Aguilar-Salinas, Elsy Canche-Pool and Vianney Ortiz-Navarrete
Affiliation:
Keywords: Natural Killer T (NKT) cells, Type 1 diabetes, Class-I MHC-restricted T-cell associated molecule (CRTAM), T lymphocyte antigen receptor (TCR), Effector lymphocytes, Human Leukocytary Antigen (HLA), Tumor Necrosis Factor, Insulitis, Hyperglycemia, Immunoglobulin
Abstract: In type 1 diabetes, a failure in the regulation of either innate or acquired immunity may be the cause of autoimmune response. A cell population that may have a regulatory role of the immune response are the Natural Killer T (NKT) cells, which are a population expressing T lymphocyte antigen receptor (TCR), and a common marker for NK cells. A distinctive characteristic in NKT cells is their capacity to produce large amounts of immune-modulating cytokines. A decrease in the number and/or functional incapability of NKT cells is associated with progression of type 1 diabetes and with other self-immune diseases. However, the relevance of such findings is not completely understood. Limitations of the current studies include the existing methods to measure NKT activation and the lack of assessment of the expression of genes affected by NKT action. Nevertheless, the study of NKT cells may be a new clinical approach to detect individuals at risk for having type 1 diabetes. Additional studies are needed to evaluate the clinical value of this new predictive tool.
Export Options
About this article
Cite this article as:
A. Gomez-Diaz Rita, V. Aguilar Mayra, N. Meguro Elisa, H. Marquez Rocio, G. Magana Eulalia, Carmen Martinez-Garcia M., W. Rodarte Niels, A. Aguilar-Salinas Carlos, Canche-Pool Elsy and Ortiz-Navarrete Vianney, The Role of Natural Killer T (NKT) Cells in the Pathogenesis of Type 1 Diabetes, Current Diabetes Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339911796397839
DOI https://dx.doi.org/10.2174/157339911796397839 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Diabetes, Obesity and Vascular Disease - An Update)
Current Pharmaceutical Design Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
Current Respiratory Medicine Reviews The Prevalence of the Classical and Non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients
CNS & Neurological Disorders - Drug Targets Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease
Current Pharmaceutical Design Targeting the Arrhythmogenic Substrate in Atrial Fibrillation: Focus on Structural Remodeling
Current Drug Targets Potential Usefulness of Clopidogrel Pharmacogenetics in Ce rebral Endovascular Procedures and Carotid Artery Stenting
Current Clinical Pharmacology Therapeutic Angiogenesis: Recent and Future Prospects of Gene Therapy in Peripheral Artery Disease
Current Gene Therapy Neurotuberculosis: An Overview
Central Nervous System Agents in Medicinal Chemistry MTHFR Gene Polymorphism and Diabetic Retinopathy
Current Diabetes Reviews Analysis and Determination of Anti-diabetes Drug Acarbose and its Structural Analogs
Current Pharmaceutical Analysis An Overview of the Effect of Weight Loss on Cardiovascular Autonomic Function
Current Diabetes Reviews Genetic Association Studies: An Information Content Perspective
Current Genomics Novel Peptides: An Alternative Approach for the Treatment of Diabetes Mellitus
Current Drug Therapy Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents
Current Computer-Aided Drug Design Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Current Vascular Pharmacology PDX-1 and MafA as Potential Therapeutic Targets for Diabetes
Current Signal Transduction Therapy Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer
Current Medicinal Chemistry Present Insights on Cardiomyopathy in Diabetic Patients
Current Diabetes Reviews Pharmacology and Perioperative Considerations for Diabetes Mellitus Medications
Current Clinical Pharmacology